Abstract:Background: Celastrol, a quinine methide triterpene extracted from a Chinese medicine (Trypterygium wilfordii Hook F.), has the potential to become an anticancer drug with promising prospects. Cell culture metabolomics has been a powerful method to study metabolic profiles in cell line after drug treatment, which can be used for discovery of drug targets and investigation of drug effects.Methods: We analyzed the metabolic modifications induced by celastrol treatment in human cervical cancer cells, using an ion-trap gas chromatography-mass spectrometry based metabolomics combined with multivariate statistical analysis, which allows simultaneous screening of multiple characteristic metabolic pathways related to celastrol treatment. Three representative apoptosis-inducing cytotoxic agents, namely cisplatin, doxorubicin hydrochloride and paclitaxel, were selected as positive control drugs to validate reasonableness and accuracy of our metabolomic investigation on celastrol.Results: Anti-proliferation and apoptotic effects of celastrol were demonstrated by CCK-8 assay, Annexin-V/PI staining method, mitochondrial membrane potential (Delta Psi m) assay and caspase-3 assay. Several significant metabolites involved in energy, amino acid and nucleic acid metabolism in HeLa cells induced by celastrol and positive drugs were reported. Our method is proved to be effective and robust to provide new evidence of pharmacological mechanism of celastrol.Conclusions: The metabolic alterations induced by drug treatment showed the impaired physiological activity of HeLa cells, which also indicated anti-proliferative and apoptotic effects of celastrol and these positive drugs.General significance: GC/MS-based metabolomic approach applied to cell culture could give valuable information on the systemic effects of celastrol in vitro and help us to further study its anticancer mechanism. (C) 2012 Elsevier B.V. All rights reserved.

Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy

Design, Synthesis and Antitumor Evaluation of Novel Celastrol Derivatives

Synthesis and Characterisation of Celastrol Derivatives As Potential Anticancer Agents

Synthesis and Biological Evaluation of a Series of Novel Celastrol Derivatives with Amino Acid Chain

Synthesis and Biological Evaluation of Celastrol Derivatives with Improved Cytotoxic Selectivity and Antitumor Activities

Design, synthesis, and evaluation of antitumor activity of novel C‐6 sulfhydryl‐substituted and 20‐substituted derivatives of celastrol

Design, Synthesis and Biological Evaluation of C(6)-Modified Celastrol Derivatives As Potential Antitumor Agents

Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway

Design And Synthesis Of Novel Celastrol Derivative And Its Antitumor Activity In Hepatoma Cells And Antiangiogenic Activity In Zebrafish

Enhanced Cancer Therapy of Celastrol in Vitro and in Vivo by Smart Dendrimers Delivery with Specificity and Biosafety

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Celastrol in cancer therapy: Recent developments, challenges and prospects

Synthesis of 3- and 29-Substituted Celastrol Derivatives and Structure-Activity Relationship Studies of Their Cytotoxic Activities.

SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells

Antitumor effect of novel celastrol analogues in vitro

Effects of Celastrol on Human Cervical Cancer Cells As Revealed by Ion-Trap Gas Chromatography–mass Spectrometry Based Metabolic Profiling

Discovery of Novel Celastrol–Imidazole Derivatives with Anticancer Activity In Vitro and In Vivo

Molecular targets of celastrol in cancer: Recent trends and advancements

Synthesis and Biological Evaluation of Celastrol Derivatives as Potential Immunosuppressive Agents

Design and Synthesis of Novel Celastrol Derivatives as Potential Anticancer Agents against Gastric Cancer Cells

Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties.